Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine‐based chemotherapy. BJS 2017; 104: 328-336.
Authors: N. T. E. Bird, M. Elmasry, R. Jones, E. Psarelli, J. Dodd, H. Malik et al.
Notes: Standardization needed to see if it's really useful
Meta‐analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid‐type fibromatosis. BJS 2017; 104: 347-357.
Authors: M. L. Janssen, D. L. M. van Broekhoven, J. M. M. Cates, W. M. Bramer, J. J. Nuyttens, A. Gronchi et al.
Notes: Radiotherapy after surgery for recurrence only
European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. BJS 2017; 104: 358-376.
Authors: S. Gaujoux, R. Mihai, B. Carnaille, B. Dousset, C. Fiori, F. Porpiglia et al.
Notes: The best evidence available
Meta‐analysis of individual‐patient data from EVAR‐1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. BJS 2017; 104: 166-178.
Authors: J. T. Powell, M. J. Sweeting, P. Ulug, J. D. Blankensteijn, F. A. Lederle, J.‐P. Becquemin et al.
Notes: Survival comparable